Rivaroxaban

Product NDC
33342-488
11-digit product format
333420488
Labeler code
33342
Product ID
33342-488_b6691115-e5df-4846-8358-79d091cdc3c0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Rivaroxaban
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Macleods Pharmaceuticals Limited
Application
ANDA213114
Marketing category
ANDA
Marketing start
2025-05-14
Substance
RIVAROXABAN
Active strength
2.5 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213114-001RIVAROXABANRIVAROXABAN2.5MGTABLET / ORALAB2025-05-14
A213114-002RIVAROXABANRIVAROXABAN10MGTABLET / ORALAB2025-05-14
A213114-003RIVAROXABANRIVAROXABAN15MGTABLET / ORALAB2025-05-14
A213114-004RIVAROXABANRIVAROXABAN20MGTABLET / ORALAB2025-05-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A213114-001AB
A213114-002AB
A213114-003AB
A213114-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A213114-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A213114-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A213114-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A213114-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213114-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213114-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213114-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213114-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213114-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213114-002RIVAROXABAN10MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213114-003RIVAROXABAN15MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213114-004RIVAROXABAN20MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08A213114-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213114-002RIVAROXABAN10MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213114-003RIVAROXABAN15MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213114-004RIVAROXABAN20MGTABLET / ORALAB2025-05-146a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213114-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213114-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213114-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213114-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A213114-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A213114-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A213114-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A213114-004AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213114-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213114-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213114-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213114-004AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213114-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213114-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213114-003AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213114-004AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A213114-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213114-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213114-003AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213114-004AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213114-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213114-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213114-003AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213114-004AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Rivaroxaban
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RIVAROXABAN2.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9NDF7JZ4M3Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2059015Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
57717a31-d9d3-4246-90c0-4e4c0a29adf5Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6cd5c957-f63d-4ae5-a5e5-4e6830870998Product name320251209

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
33342-488-09Rivaroxaban60 in 1 BOTTLETABLET, FILM COATED604
33342-488-57Rivaroxaban180 in 1 BOTTLETABLET, FILM COATED1804
33342-488-98Rivaroxaban10 in 1 CARTONTABLET, FILM COATED104
33342-488-98Rivaroxaban6 in 1 BLISTER PACKTABLET, FILM COATED64

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
33342-488-09EA - Each33342-48823337fc5-55ad-47d5-b169-c971e9c8b01f12025-06-13
33342-488-57EA - Each33342-488608871e9-0e07-40d5-a93b-1524871c3ac812025-06-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
33342-488RIVAROXABAN TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED]2Current NDC, 4 package rows20250522_57717a31-d9d3-4246-90c0-4e4c0a29adf5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RivaroxabanRIVAROXABANNorthStar RxLLC88246a0e-befe-4dc6-81e1-4b7adc266db22026-06-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213114
application number: ANDA213114
RivaroxabanRIVAROXABANMacleods Pharmaceuticals Limited57717a31-d9d3-4246-90c0-4e4c0a29adf52026-04-06Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213114
application number: ANDA213114
ndc (product): 33342-488

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2059015rivaroxaban 2.5 MG Oral TabletPSN57717a31-d9d3-4246-90c0-4e4c0a29adf54
2059015rivaroxaban 2.5 MG Oral TabletSCD57717a31-d9d3-4246-90c0-4e4c0a29adf54

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
33342-488-093334204880960 TABLET, FILM COATED in 1 BOTTLE (33342-488-09) 2025-05-14NoNoCurrent
33342-488-5733342048857180 TABLET, FILM COATED in 1 BOTTLE (33342-488-57) 2025-05-14NoNoCurrent
33342-488-983334204889810 BLISTER PACK in 1 CARTON (33342-488-98) / 6 TABLET, FILM COATED in 1 BLISTER PACK10 blister pack2025-05-14NoNoCurrent